Pulsenmore's home ultrasound solution for pregnant women expands in a clinical trial with Michigan Medicine, enabling remote fetal biophysical profile assessment.

Pulsenmore expands its home ultrasound solution for pregnant women in a clinical trial with Michigan Medicine, focusing on remote assessment of the fetal biophysical profile. The solution empowers pregnant women to perform ultrasound scans from home, transmitting results for evaluation & communication with clinicians. With over 100,000 successful scans, the technology aims to reduce in-clinic visits & traditional antenatal testing.

March 13, 2024
4 Articles

Further Reading